C4 Therapeutics Presents Clinical Data from Cohort A of the Ongoing Phase 1/2 Clinical Trial of CFT7455, a Novel IKZF1/3 Degrader
– Single Agent CFT7455 Induces Deep and Durable Degradation of IKZF1/3 and Meaningful Decreases in…
News
Biomea Fusion Reports Preclinical Data on BMF-219 and Trial in Progress Presentations at AACR 2022 Annual Meeting
Covalent menin inhibitor BMF-219 showed strong cytotoxic activity as a single agent at similar concentrations across…
Theratechnologies Presents New In Vivo TH1902 Preclinical Data Demonstrating Tumor Growth Inhibition of Human Cancer Stem-Like Cells (CD133+) in Both Triple-Negative Breast and Ovarian Cancers AACR Annual Meeting 2022
Two Additional Preclinical Proof-of-concept Posters in Ovarian and Metastatic Lung Cancer Models Also Presented at…
Werewolf Therapeutics Presents Promising Preclinical Data on its Two Lead INDUKINE™ Molecules at AACR 2022 Annual Meeting
WTX-124 demonstrated high tumor selectivity and generated significant anti-tumor activity in a CD8+ T cell-dependent…
Ultimovacs Presents TET Platform Pre-Clinical Data at AACR 2022 Supporting Clinical Development
TET platform shows efficient T cell priming and beneficial safety profile Data supported clinical transition…
ImCheck Provides Updated ICT01 and Pembrolizumab Combination Data from the Phase I/IIa EVICTION Trial at AACR Annual Meeting 2022
ImCheck Provides Updated ICT01 and Pembrolizumab Combination Datafrom the Phase I/IIa EVICTION Trial at AACR…
Introducing Bitcoin City – The First Crypto City in Metaverse
Riga, Latvia–(Newsfile Corp. – April 8, 2022) – The Bitcoin City project is the metaverse’s…
KBRA Releases Solar Loan Index for March 2022
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its solar loan index publication, providing monthly credit trends of securitized…
KBRA Releases RMBS Credit Indices (KCI) for March 2022
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its RMBS Credit Indices (KCI) for March 2022. The indices track…
Kim & Serritella LLP and Barton LLP Announce a Securities Class Action Against Uniswap and Other Defendants Regarding the Unregistered Offer and Sale of Digital Tokens, and Lead Plaintiff Deadline
NEW YORK–(BUSINESS WIRE)–Kim & Serritella LLP and Barton LLP announce that a securities class action,…
Transgene to Present New Positive Preliminary Phase I Clinical Data at AACR 2022, Reinforcing the Potential of TG4050
Transgene will discuss new immunogenicity and clinical data generated with TG4050 that reinforce the strong…
PathAI Announces Upcoming Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting
BOSTON–(BUSINESS WIRE)–#aacr22—PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, today announced that…
DEINOVE presents its financial results and the advancement of its programs for 2021
DEINOVE presents its financial results and the advancement of its programs for 2021 Favorable opinion…
Ultimovacs ASA – Disclosure of voting rights of Annual General Meeting
Oslo, 08 April 2022: In connection with the Annual General Meeting of Ultimovacs ASA to…
BioNTech Granted Pandemic Preparedness Contract by German Federal Ministry of Health
MAINZ, Germany, April 8, 2022 — BioNTech SE (Nasdaq: BNTX) today announced that it is…
BioCryst Pauses Enrollment in BCX9930 Clinical Trials
RESEARCH TRIANGLE PARK, N.C., April 08, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today…
Medicenna Announces Preclinical Data Highlighting the Potent Anti-Tumor Efficacy of Anti-PD1-IL-2 BiSKIT at the AACR Annual Meeting
— Anti-PD1-IL-2 BiSKIT (Bi-functional SuperKines for ImmunoTherapy) selectively stimulates anti-cancer immune cells via IL-2 agonism and prevents…
Bioventus TheraSkin Coverage Expands to Provide for 17 Million More Covered Lives
DURHAM, N.C., April 08, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
Medicenna Presents Preclinical Data Demonstrating Anti-Cancer Activity of a Long-Acting IL-13 Super-Antagonist at the AACR Annual Meeting
— Fc-MDNA413 suppresses pro-tumor immune pathways by simultaneously inhibiting IL-4 / IL-13 mediated signaling and…
SCCG and RONIN Partner for North America TV Sports Data
LAS VEGAS, NV, Apr 8, 2022 – (ACN Newswire) – SCCG Management CEO and Founder…